Review



phospho src tyr416  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc phospho src tyr416
    Phospho Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 2356 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/Phospho-Src+Family+(Tyr416)+Antibody/us12594421-308-66-69
    Average 96 stars, based on 2356 article reviews
    phospho src tyr416 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Membrane:

    Article Title: Selective Azapeptide CD36 Ligand MPE-298 Regulates oxLDL-LOX-1-Mediated Inflammation and Mitochondrial Oxidative Stress in Macrophages.
    Article Snippet: Prolume Purple (Methoxy e-CTZ) was purchased from NanoLight TechnologyTM (Pinetop, AZ, USA); the pCMV3-mCD36 C-GFPSpark tag for mCD36 expression from Sino Biologicals Inc. (Beijing, China); TransIT-X2® Dynamic Delivery System from Mirus Bio LCC (Madison, WI, USA); Alexa-fluor®594 anti-rabbit IgG, Clone 6B9G9, isotype Mouse IgG1κ, macrophage colony-stimulating factor (rmM-CSF), and interferon gamma (IFNγ) all from BioLegend (San Diego, CA, USA); cytochalasin D (actin polymerization inhibitor), PP1, PP2 (Src inhibitors), piceatannol (Syk kinase inhibitor), ATTO465 N-hydroxysuccinimidyl-esters (NHS), and E. coli (0111:B4) lipopolysaccharide (LPS) all from Sigma-Millipore (St. Louis, MO, USA); MitoSox-Red, Hoechst-33342, 5,5′,6,6′- tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), CellLightTM Late Endosomes-RFP, and CellLightTM Lysosomes-RFP all from Invitrogen-Life Technologies (Carlsbad, CA, USA); and inhibitors 2-bromohexadecanoic acid (2-bromopalmitate, inhibitor of depalmitoylation), sulfosuccinimidyl oleate (SSO, CD36 inhibitor), and BI-0115 (LOX-1 inhibitor) from AbMole BioScience (Houston, TX, USA), Cayman Chemical (Ann Arbor, MI, USA), and MedChemExpress (Monmouth Junction, NJ, USA), respectively. .. Antibodies against early endosome antigen 1 (EEA1), Rab7, Rab11, lysosome-associated membrane protein (Lamp) 1, Rac1/2/3, phospho-Tyr416 and total Src family kinases, phosphoTyr397 and total Lyn, JNK and phospho-(Thr183/Tyr185) JNK, all were purchased from Cell Signaling (Danvers, MA, USA). .. SHC-adaptor protein 1 (Shc1) was from R&D System (Minneapolis, MN, USA). p47phox was from Novus Biologicals (Minneapolis, MN, USA).

    Article Title: Selective Azapeptide CD36 Ligand MPE-298 Regulates oxLDL-LOX-1-Mediated Inflammation and Mitochondrial Oxidative Stress in Macrophages
    Article Snippet: Prolume Purple (Methoxy e-CTZ) was purchased from NanoLight Technology TM (Pinetop, AZ, USA); the pCMV3-mCD36 C-GFPSpark tag for mCD36 expression from Sino Biologicals Inc. (Beijing, China); TransIT-X2 ® Dynamic Delivery System from Mirus Bio LCC (Madison, WI, USA); Alexa-fluor ® 594 anti-rabbit IgG, Clone 6B9G9, isotype Mouse IgG1κ, macrophage colony-stimulating factor (rmM-CSF), and interferon gamma (IFNγ) all from BioLegend (San Diego, CA, USA); cytochalasin D (actin polymerization inhibitor), PP1, PP2 (Src inhibitors), piceatannol (Syk kinase inhibitor), ATTO-465 N-hydroxysuccinimidyl-esters (NHS), and E. coli (0111:B4) lipopolysaccharide (LPS) all from Sigma-Millipore (St. Louis, MO, USA); MitoSox-Red, Hoechst-33342, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), CellLight TM Late Endosomes-RFP, and CellLight TM Lysosomes-RFP all from Invitrogen-Life Technologies (Carlsbad, CA, USA); and inhibitors 2-bromohexadecanoic acid (2-bromopalmitate, inhibitor of depalmitoylation), sulfosuccinimidyl oleate (SSO, CD36 inhibitor), and BI-0115 (LOX-1 inhibitor) from AbMole BioScience (Houston, TX, USA), Cayman Chemical (Ann Arbor, MI, USA), and MedChemExpress (Monmouth Junction, NJ, USA), respectively. .. Antibodies against early endosome antigen 1 (EEA1), Rab7, Rab11, lysosome-associated membrane protein (Lamp) 1, Rac1/2/3, phospho-Tyr416 and total Src family kinases, phospho-Tyr397 and total Lyn, JNK and phospho-(Thr183/Tyr185) JNK, all were purchased from Cell Signaling (Danvers, MA, USA). .. SHC-adaptor protein 1 (Shc1) was from R&D System (Minneapolis, MN, USA). p47phox was from Novus Biologicals (Minneapolis, MN, USA).



    Similar Products

    phospho src tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc phospho src tyr416
    Phospho Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/Phospho-Src+Family+(Tyr416)+Antibody/us12594421-308-66-69
    Average 96 stars, based on 1 article reviews
    phospho src tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    phospho src family tyr416 d49g4 rabbit mab  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc phospho src family tyr416 d49g4 rabbit mab
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Phospho Src Family Tyr416 D49g4 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/bio_rxiv__64898__2026__04__02__716058-74-6-39
    Average 86 stars, based on 1 article reviews
    phospho src family tyr416 d49g4 rabbit mab - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    antibodies phospho src family tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc antibodies phospho src family tyr416
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Antibodies Phospho Src Family Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/Phospho-Src+Family+(Tyr416)+Antibody/pm41914886-205-7-11
    Average 96 stars, based on 1 article reviews
    antibodies phospho src family tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    phospho c src tyr416 d49g4 cell signaling technology  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc phospho c src tyr416 d49g4 cell signaling technology
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Phospho C Src Tyr416 D49g4 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/10__3390_slash_cancers18071082-84-3-6
    Average 86 stars, based on 1 article reviews
    phospho c src tyr416 d49g4 cell signaling technology - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    cell signaling technology 2101  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc cell signaling technology 2101
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Cell Signaling Technology 2101, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/Phospho-Src+Family+(Tyr416)+Antibody/pm41882003-400-96-96
    Average 96 stars, based on 1 article reviews
    cell signaling technology 2101 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    anti phospho src tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc anti phospho src tyr416
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    Anti Phospho Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/Phospho-Src+Family+(Tyr416)+Rabbit+mAb/pm41866450-70-43-49
    Average 96 stars, based on 1 article reviews
    anti phospho src tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    c src family phospho tyr416  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc c src family phospho tyr416
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    C Src Family Phospho Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/Phospho-Src+Family+(Tyr416)+Rabbit+mAb/pm41871717-58-48-63
    Average 96 stars, based on 1 article reviews
    c src family phospho tyr416 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    p src  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc p src
    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
    P Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+tyr416/Phospho-Src+Family+(Tyr416)+Antibody/pm41858068-64-44-47
    Average 96 stars, based on 1 article reviews
    p src - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation (Tyr416), and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.

    Journal: bioRxiv

    Article Title: Heterogeneous Sensitivity to Src Inhibitors in Oral Squamous Cell Carcinoma and Its Implications for Combination Therapy with Cisplatin

    doi: 10.64898/2026.04.02.716058

    Figure Lengend Snippet: A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation (Tyr416), and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.

    Article Snippet: The following primary antibodies were used: Phospho-Src Family (Tyr416) (D49G4) Rabbit mAb (#6943), Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP Rabbit mAb (#4370), Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP Rabbit mAb (#4511), and Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb (#4668) (all from Cell Signaling Technology).

    Techniques: Western Blot, Protein-Protein interactions, Control, Standard Deviation, Activity Assay, Phospho-proteomics